Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamfetamine for severe fatigue in glioma
NCT02363075Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2013
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of adenosine-5′-monophosphate in fatigue, sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
adenosine-5′-monophosphate
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT02363075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02363075.